Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
ETHRANE (enflurane) is a volatile liquid anesthetic administered via inhalation for general anesthesia induction and maintenance. It has been a standard inhalational anesthetic since 1972, used primarily in operating room settings. Enflurane works as a central nervous system depressant to produce unconsciousness and analgesia during surgical procedures.
Product is in late-stage lifecycle with moderate competitive pressure (30/100); expect declining team size and shift toward maintenance-focused roles rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on ETHRANE offers stability in a mature, well-established product but limited growth upside; career advancement will depend on mastery of operational efficiency, cost management, and legacy product stewardship. This role is best suited for professionals seeking deep expertise in anesthetic manufacturing and supply chain rather than product innovation.
Worked on ETHRANE at Baxter? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.